Translating the nuanced risk for substance use among adolescents treated for attention‐deficit/hyperactivity disorder ( ADHD ) into clinical practice

In their recent examination of the Monitoring the Future (MTF) data, McCabe et al. (Journal of Child Psychology and Psychiatry, 2023) address the complex, longstanding, and clinically valuable questions of whether and how stimulant medication treatment for adolescents with ADHD relates to their risk for substance use. Here, we expand on the authors' interpretations of their nuanced findings of increased risk for illicit stimulant use and non‐prescribed stimulant medication use for youth with later age of medication treatment initiation and shorter treatment duration. We particularly focus on highlighting tangible clinical implications, and we recommend ways future research can build on the authors' findings to further clarify this important issue

Atomoxetine · Conduct disorder · Developmental psychology · Methylphenidate · Psychiatry · Stimulant · Substance use · Attention Deficit Hyperactivity Disorder · Clinical Psychology · Neuroethics, Human Enhancement, Biomedical Innovations · Pharmaceutical studies and practices · Psychology

• Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse

  Open Access•Sean Esteban Mccabe, Olivia Figueroa et al.•Journal of Child Psychology and…•2024

  Add to list